TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity

BACKGROUND: Dysregulated transforming growth factor β (TGFβ) signaling is implicated in osteoarthritis development, making normalizing TGFβ signaling a possible therapy. Theoretically, this can be achieved with small molecule inhibitors specifically targeting the various TGFβ receptors and downstrea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: van Caam, Arjan, Madej, Wojciech, Garcia de Vinuesa, Amaya, Goumans, Marie-José, ten Dijke, Peter, Blaney Davidson, Esmeralda, van der Kraan, Peter
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5452635/
https://ncbi.nlm.nih.gov/pubmed/28569204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1302-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars